Pilianidis, G., Papanastasiou, G., Tikoudi, P., Themistocleous, A., Farmakis, G., & Dolianitis, K. (2024). Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections? European Journal of Case Reports in Internal Medicine, 11(3). https://doi.org/10.12890/2024_004282